An Ipamorelin certificate of analysis (COA) is an official analytical document verifying a specific peptide lot's identity, chemical purity, and safety profile. It reports empirical data from Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC), Mass Spectrometry (MS), and Limulus Amebocyte Lysate (LAL) endotoxin assays to confirm laboratory-grade quality.
An Ipamorelin certificate of analysis (COA) is an official analytical document verifying a specific peptide lot's identity, chemical purity, and safety profile. It reports empirical data from Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC), Mass Spectrometry (MS), and Limulus Amebocyte Lysate (LAL) endotoxin assays to confirm laboratory-grade quality.
A lot-specific Ipamorelin certificate of analysis serves as the primary verification document for principal investigators, analytical chemists, and biomedical researchers evaluating research-grade peptides. Rather than relying on static specifications, a valid COA reflects direct testing performed on the final lyophilized batch by an independent, ISO 17025 accredited laboratory.
The document details key physical and chemical metrics, including visual appearance, solubility, counterion content, chromatographic purity, exact molecular mass, and bacterial endotoxin levels. Accessing batch-specific analytical reports ensures that experimental models—ranging from ghrelin receptor binding studies to pulsatile hormone release assays—are conducted with verified, unadulterated research peptides.
Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2Nal-D-Phe-Lys-NH2 and a theoretical molecular weight of 711.86 g/mol. Classified structurally as a growth hormone secretagogue (GHS), Ipamorelin binds selectively to the growth hormone secretagogue receptor 1a (GHS-R1a) located on pituitary somatotropes and hypothalamic nuclei.
Preclinical studies suggest that Ipamorelin activates downstream signaling pathways via receptor dimerization, stimulating the selective, pulsatile release of growth hormone (GH). In vitro and animal models demonstrate that unlike broader-spectrum secretagogues, Ipamorelin induces robust GH release without triggering significant concurrent elevations in adrenocorticotropic hormone (ACTH), cortisol, or prolactin. Maintaining high chemical purity via a documented ipamorelin certificate of analysis is critical to preventing non-specific receptor crosstalk caused by truncated peptide impurities.
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold standard for establishing peptide purity. During testing, the sample is dissolved in an aqueous mobile phase and driven through a hydrophobic stationary phase (typically C18 silica) under an acetonitrile gradient. Detection is performed using ultraviolet spectrophotometry, generally calibrated at 214 nm or 220 nm to capture peptide backbone absorption.
On an authentic COA, the HPLC chromatogram displays a single, sharp principal peak corresponding to intact Ipamorelin. Minor secondary peaks represent synthesis impurities, such as deletion sequences or stereoisomers generated during solid-phase peptide synthesis (SPPS). Total purity is calculated by integrating the area under the curve (AUC) of the primary peak against all detectable signals. PX1 Research mandates that every batch of Ipamorelin meets or exceeds a strict 98% purity threshold.
While RP-HPLC establishes sample homogeneity, Mass Spectrometry (MS)—typically utilizing Electrospray Ionization (ESI) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF)—confirms exact molecular identity. Mass spectral analysis measures the mass-to-charge ratio (m/z) of ionized peptide fragments.
For Ipamorelin, the theoretical monoisotopic mass is 711.86 Da. The mass spectrum on a valid COA will demonstrate a major peak at [M+H]+ (712.86 m/z) or multi-charged states such as [M+2H]2+. Matching the empirical mass against the theoretical chemical structure confirms that the peptide sequence contains the correct amino acid composition without unexpected oxidation, protecting-group retention, or amino acid substitution.
Bacterial endotoxins—primarily lipopolysaccharides (LPS) derived from Gram-negative cell walls—pose a major confounding variable in biological research. In cellular and preclinical animal models, minute endotoxin contamination can trigger inflammatory cytokine cascades, fever responses, or altered cell viability, invalidating experimental outcomes.
Quality testing reported on an ipamorelin certificate of analysis includes quantitative Limulus Amebocyte Lysate (LAL) testing per USP <85> guidelines. Results are expressed in Endotoxin Units per milligram (EU/mg). High-purity research compounds supplied by PX1 Research undergo rigorous endotoxin screening to ensure levels remain well below established preclinical limits (<0.1 EU/mg), making them suitable for delicate in vitro assays and rodent physiological studies.
Lyophilized Ipamorelin is shipped as a stable, sterile-filtered cake. Upon receipt, the sealed vial should be stored in a freezer at -20°C or -80°C for long-term stability, protected from light and moisture. To prepare the compound for benchtop protocols, researchers utilize an appropriate diluent such as sterile bacteriostatic water or phosphate-buffered saline (PBS).
Reconstitution should involve gently directing the solvent down the inner glass wall of the vial rather than applying direct force onto the lyophilized powder. The vial should be gently swirled until completely dissolved; vortexing should be avoided to prevent mechanical shear stress. For precise volumetric calculations, consult our dedicated Ipamorelin reconstitution calculator guide.
When designing preclinical protocols investigating growth hormone axis modulation, researchers frequently compare Ipamorelin against other synthetic growth hormone secretagogues. Structural and receptor binding selectivity varies significantly across peptide classes:
While early-generation peptides like GHRP-2 and GHRP-6 induce potent growth hormone release, rodent models indicate they also stimulate mild to moderate elevations in systemic cortisol and prolactin via secondary neuroendocrine pathways. Conversely, Ipamorelin provides targeted GHS-R1a agonism without secondary endocrine stimulation. When co-administered with a growth hormone-releasing hormone (GHRH) analog such as CJC-1295 without DAC, preclinical literature demonstrates a synergistic increase in pulsatile growth hormone amplitude. Verifying the purity of each compound via individual batch COAs is crucial when conducting comparative or combination secretagogue research.
PX1 Research is committed to supplying American-manufactured, research-grade peptides produced in state-of-the-art, GMP-compliant facilities. Every production batch undergoes comprehensive quality control testing performed by independent, ISO 17025 accredited analytical laboratories.
We maintain total supply chain transparency by publishing lot-specific certificates of analysis containing unedited RP-HPLC chromatograms, ESI-MS spectra, and LAL endotoxin data. Orders placed through PX1 Research ship same-day (Monday through Friday) directly from our centralized distribution hubs in California and Arizona. Institutional buyers requiring specialized documentation or bulk quantities can request custom analytical testing through our dedicated wholesale laboratory portal.
What is the minimum purity level required on an Ipamorelin COA for research use?
For reliable in vitro and preclinical research, Ipamorelin should demonstrate a minimum HPLC chromatographic purity of 98.0%, with premium analytical batches reaching >99.0% purity.
How do I verify the authenticity of an ipamorelin certificate of analysis?
An authentic COA features a unique batch/lot number, testing date, clear HPLC chromatogram showing peak integration tables, mass spectrometry data matching the theoretical mass (711.86 g/mol), and accreditation details from an independent ISO 17025 testing facility.
What molecular mass peak should appear on the Ipamorelin mass spectrometry report?
The expected theoretical molecular mass of Ipamorelin is 711.86 Da. The mass spectrum typically displays a predominant single-protonated adduct [M+H]+ at 712.86 m/z.
Why is endotoxin testing critical on a peptide COA?
Endotoxins cause inflammatory responses in biological systems that can distort cell culture dynamics, alter neuroendocrine responses, and induce systemic toxicity in preclinical animal models, confounding experimental data.
How does Ipamorelin differ from GHRP-2 on an analytical report?
Ipamorelin (Aib-His-D-2Nal-D-Phe-Lys-NH2, MW 711.86 g/mol) and GHRP-2 (D-Ala-D-2Nal-Ala-Trp-D-Phe-Lys-NH2, MW 817.97 g/mol) have distinct molecular structures, resulting in different HPLC retention times and distinct mass spectrometry peaks.
How should reconstituted Ipamorelin be stored in the laboratory?
After reconstitution with sterile bacteriostatic water or buffer, liquid aliquots should be stored at 2°C to 8°C for short-term evaluation (up to 30 days) or frozen at -20°C for extended storage, avoiding repeated freeze-thaw cycles.
Does Ipamorelin cause elevated cortisol or prolactin levels in research models?
Preclinical studies show that Ipamorelin selectively stimulates growth hormone release from somatotropes without inducing significant cortisol or prolactin secretion, unlike older secretagogues.
How can my institution obtain a lot-specific COA from PX1 Research?
Lot-specific certificates of analysis are accessible directly on our product pages or by contacting our analytical support team with your order lot number.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.